Management Treatment of Bleeding Disorders Hemophilia

Blood Management for Treatment of Hemophilia and Other Bleeding Disorders

Bleeding Disorders Hemophilia is serious conditions that affect a large number of people around the world. Hemophilia affects nearly 20,000 people in the United States and more than 400 children are born each year with the disorder. Severe cases of hemophilia occur almost predominantly in men but women can still be carriers of the gene that causes hemophilia.

Other forms of bleeding disorders hemophilia include:

  • Acquired platelet function defects
  • platelet function defects
  • Congenital antithrombin III deficiency
  • Congenital protein C or S deficiency
  • Disseminated intravascular coagulation (DIC)
  • Drug-induced immune thrombocytopenia
  • Idiopathic thrombocytopenic purpura (ITP)
  • Von Willebrand’s disease

Do you know Bleeding disorders hemophilia can result from a number of different causes? The most common element of these disorders is a lack of blood parts responsible for clotting (platelets). The result’s excessive or significant trauma that takes longer for the body to regulate.

Blood Transfusions as Treatment for Hemophilia

In the of the twentieth century, it was common for hemophilia patients with other clotting disorders to be treated with blood transfusions. The process ab initio concerned the transfusion of blood or frozen plasma. This was a laborious process, requiring extended hospital stays for each treatment.

During the 1970s and 80s, the specific clotting factors in the blood became available in more convenient, concentrated forms. Since the natural factors were the sole elements of a hemophiliac from different patients with hurt disorders needed from the complete blood or plasma, blood transfusions were no longer necessary.

By 1987, it became evident that associate horrendous variety of hemophile and different hurt disorder patients had become infected with serum hepatitis, hepatitis C, and HIV (the virus that causes AIDS) due to contaminated donor blood.

Although major strides have been made since the late 1980s to improve the safety of donor blood. Patients with hemophilia and other bleeding disorders are at risk for any bloodborne pathogen.

Blood Management for Treating Hemophilia

The advent of bloodless medication, has provided new alternatives for treating hemophilia and other bleeding disorders hemophilia. The field of bloodless medicine involves a number of different techniques and new technologies that can minimize the loss of blood during major surgeries.

Does one such technique involve a gene-modified bone marrow transplant? The patient’s own bone marrow is removed and the stem cells contained in it are treated with Factor VIII. The modified bone marrow is transplanted back to the patient, who is now able to produce blood platelets retaining the essential.

These kinds of treatments also have the potential to allow patients to lead a more “normal” life, without frequent hospital visits. Some hemophiliacs need frequent blood transfusions – as several as 3 per week. Newer treatments utilizing blood management techniques and analysis have the potential to drastically cut back treatment times.

Contact hospital or tending system for additional info concerning blood management programs that may be accessible close to you.